Inventor · disambiguated record
Raanan Margalit
Also filed as: MARGALIT RAANAN
11 granted patents·11 pending applications·51 citations·filing 1993–2024
87Inventor score
Top patents by PatentIndex Score
22 records- 0184US11852634B2Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating sameYEDA RES & DEV·Filed 2020·Granted Dec 26, 2023·1 cites·3 claims
- 0277US6750207B1Compositions for the regulation of cytokine activityYEDA RES & DEV·Filed 2000·Granted Jun 15, 2004·6 cites·5 claims
- 0374US6020323ACompositions and methods for regulation of active TNF-αYEDA RES & DEV·Filed 1995·Granted Feb 1, 2000·31 cites·17 claims
- 0471US11992533B2Methods of treatment of HLA-B27 related inflammatory diseases and compositions related to sameALMA BIO THERAPEUTICS·Filed 2022·Granted May 28, 2024·0 cites·20 claims
- 0571US2025018057A1Methods of treatment of hla-b27 related inflammatory diseases and compositions related to sameSTALHAMER MICHAEL·Filed 2024·Application pending·0 cites
- 0670US7285536B2Anti-cancer therapeutic compoundsYEDA RES & DEV·Filed 2001·Granted Oct 23, 2007·2 cites·28 claims
- 0766US8697078B2Antibodies that inhibit metalloproteinsSAGI IRIT·Filed 2011·Granted Apr 15, 2014·1 cites·16 claims
- 0863US7332480B2Compositions for the regulation of cytokine activityYEDA RES & DEV·Filed 2004·Granted Feb 19, 2008·0 cites·19 claims
- 0959US2019204340A1Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating sameYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 1058US5861382AMethods for regulation of active TNF-αYEDA RES & DEV·Filed 1993·Granted Jan 19, 1999·9 cites·5 claims
- 1155US10288622B2Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating sameYEDA RES & DEV·Filed 2015·Granted May 14, 2019·0 cites·6 claims
- 1254US9217041B2Antibodies that inhibit metalloproteinsYEDA RES & DEV·Filed 2014·Granted Dec 22, 2015·0 cites·13 claims
- 1354US8987263B2Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agentsSHINITZKY MEIR·Filed 2003·Granted Mar 24, 2015·1 cites·17 claims
- 1453US2014088017A1Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating sameUNIVERSITAETSKLINIKUM HAMBURG·Filed 2012·Application pending·0 cites
- 1550US2023321276A1Nucleic acid therapy for differential modulation of host microfloraALMA BIO THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1650US2015011471A1Regeneration of islet beta cells by hsp60 derived peptidesYEDA RES & DEV·Filed 2013·Application pending·0 cites
- 1749US2020114022A1Methods of treatment of hla-b27 related inflammatory diseases and compositions related to sameALMA BIO THERAPEUTICS·Filed 2018·Application pending·0 cites
- 1842US2015157588A1Pharmaceutical Composition Comprising Amino-Phenyl-Acetic Acid Octadec-(Z)-9-enyl Ester and Use Thereof for Treating TumorsYEDA RES & DEV·Filed 2013·Application pending·0 cites
- 1942US2015018271A1Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetesYEDA RES & DEV·Filed 2013·Application pending·0 cites
- 2041US2004247604A1Anti-inflamatory fatty alcohols and fatty acid esters useful as antigen carriersFiled 2002·Application pending·0 cites
- 2140US2006183797A1Fatty alcohols and fatty acid esters useful for treatment of inflammationCOHEN IRUN R·Filed 2002·Application pending·0 cites
- 2237US2003216635A1Method and system for monitoring pancreatic pathologiesFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →